Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02160587 · ClinicalTrials.gov registry record · Phase 1
Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA
A Phase 1 study, sponsored by Zurex Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 208
- Enrollment target
NCT02160587 is a Phase 1 study that has completed, run by Zurex Pharma. The registered enrollment target is 208 participants.
The verdict
NCT02160587, a Phase 1 study, has completed, sponsored by Zurex Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 208 participants
- Enrollment target
Study Summary
This is a safety study to determine the skin sensitization potential of ZuraPrep™ and ZuraPrep™ without isopropyl alcohol (IPA) after repetitive patch applications to skin of human subjects. Indications of both sensitization and skin irritation will be evaluated.
Interventions
- DRUG 0.9% Physiological Saline
- OTHER ZuraPrep without IPA
- DRUG Chloraprep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2014-07 |
| Est. Completion | 2014-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02160587
The ClinicalTrials.gov registry entry for NCT02160587 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zurex Pharma, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 0.9% Physiological Saline is the first listed.
NCT02160587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02160587 about?
NCT02160587 is a clinical study titled "Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA". This is a safety study to determine the skin sensitization potential of ZuraPrep™ and ZuraPrep™ without isopropyl alcohol (IPA) after repetitive patch applications to skin of human subjects. Indications of both sensitization and skin irritation will be evaluated.
What is the current status of trial NCT02160587?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 208 participants. The study started on 2014-07. Estimated completion is 2014-10.
What interventions are being tested in trial NCT02160587?
The interventions under investigation include: 0.9% Physiological Saline (DRUG), ZuraPrep without IPA (OTHER), Chloraprep (DRUG).
Who is sponsoring clinical trial NCT02160587?
This trial is sponsored by Zurex Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.